PQA partnership will create rubric for patient-centered quality measurementThe Pharmacy Quality Alliance is collaborating with NHC and NQF to create a patient-engagement rubric specific to quality measurement. MinuteClinic, CDC partner to combat antibiotic resistanceCVS Health's MinuteClinic is joining in the Centers for Disease Control and Prevention’s yearlong Antimicrobial Resistance Challenge. Coram CVS Specialty Home Infusion Services gets Joint Commission's Gold Seal of Approval Coram CVS Specialty Home Infusion Services has received The Joint Commission's Gold Seal of Approval for the third time. AAM, 28 groups oppose barriers to generics, biosimilar access in USMCA The AAM is expressing opposition, along with 28 groups, over the U.S. Mexico-Canada Agreement for its potential to keep drug prices high. Lupin receives FDA blessing for generic Pulmicort Lupin has received the FDA's nod for generic Pulmicort, which had a market value of about $474.5 million. Janssen gets FDA green light for new Invokana indication Janssen's oral diabetes treatment is the first oral diabetes treatment to have an indication to reduce the risk of heart attack, stroke or cardiovascular death, the company said. Cipla gets FDA OK for generic Valcyte The FDA has approved Cipla's generic Valcyte, which had a market value of about $79 million. Xellia rolls out vancomycin Xellia is unveiling vancomycin hydrochloride for injection, which had a market value of $338 million, according to IQVIA. Amgen's Kyprolis' new dosing option gets FDA nod Amgen's Kyprolis now offers patients with relapsed or refractory multiple myeloma the option of a more convenient dosing regime. Theravance Biopharma, Mylan get FDA approval for Yupelri Yupelri is the first and only once-daily nebulized bronchodilator approved for the treatment of COPD, the companies said. First Previous 537 538 539 540 541 Next Last
